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Risk factors of HIV-related oral 
lesions in adults
Fatores de risco de lesões bucais 
associadas ao HIV em adultos
ABSTRACT
OBJECTIVE: To assess the risk factors in the occurrence of oral lesions in 
HIV-positive adults.
METHODS: A retrospective analytical-descriptive survey was conducted using 
the medical/dental records of 534 patients with oral lesions associated with 
HIV. The data were collected from fi ve referral centers for managing HIV and 
associated comorbidities in the city of Porto Alegre, Southern Brazil, between 
1996 and 2011. Using a standardized form, socio-demographic and clinical data 
were recorded. Exclusively and defi nitively diagnosed oral pathologies were 
included and classifi ed according to ECC criteria on Oral Problems Related 
to HIV Infection. For data analysis cross-tabulations, Chi-squared tests and 
logistic regression models were used where appropriate.
RESULTS: CD4+ counts lower than 350 cells/mm³ (p < 0.001), alcohol 
consumption (p = 0.011) and female gender (p = 0.031) were predisposing 
factors for oral candidiasis. The occurrence of hairy leukoplakia was 
independently associated with CD4+ counts below 500 cells/mm³, (p = 0.029) 
a viral load above 5,000 copies/mm³ (p = 0.003) and smoking (p = 0.005). 
CONCLUSIONS: Moderate and severe degrees of immunodefi ciency and 
detectable viral loads were risk factors for the onset of oral lesions. Smoking 
and alcohol consumption also increased susceptibility to the development of 
opportunistic infections in HIV-positive adults from Porto Alegre, irrespective 
of the use of antiretroviral therapy.
DESCRIPTORS: AIDS-Related Opportunistic Infections, epidemiology. 
Oral Manifestations. Risk Factors. HIV Infections. Acquired 
Immunodefi ciency Syndrome. Cross-Sectional Studies.
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Porto Alegre, in Southern Brazil, is the city which has 
the highest incidence of AIDS in Brazil (99.8:100,000 
inhabitants) since 2006.a Around 21,000 cases of 
this syndrome had been reported reported by 2010 
and occurred mostly in adults (98.5%) with a 38.7% 
mortality rate. HIV/AIDS remains a major public health 
problem in this city, attributed principally to diagnosis 
in late stages of the disease, delayed commencement 
of highly active antiretroviral therapy (HAART) and 
poor treatment compliment.b
HIV causes the infected host to become susceptible to a 
wide spectrum of life-threatening secondary infections, 
malignant neoplasms and other disorders.1 The devel-
opment of oral tissue lesions associated with HIV is a 
frequent clinical fi nding in Brazil.21 Despite the use of 
HAART, more than 50% of HIV/AIDS carriers present 
opportunistic infections in the oral cavity.10 Especially 
oral candidiasis (OC) and hairy leukoplakia (HL) 
which are considered to be of the utmost importance 
RESUMO
OBJETIVO: Analisar fatores de risco para a ocorrência de lesões bucais em 
adultos soropositivos para o HIV.
MÉTODOS: Estudo transversal, descritivo analítico de prontuários médicos/
odontológicos de 534 pacientes com lesões bucais associadas ao HIV em 
Porto Alegre, RS, no período de 1996 a 2011. Os dados foram coletados 
em cinco centros de referência em saúde para o atendimento de portadores 
do HIV e comorbidades associadas. Os dados sociodemográfi cos e clínico-
laboratoriais foram coletados em formulários padronizados. Foram incluídos 
dados exclusivamente de lesões com diagnóstico defi nitivo e classifi cadas de 
acordo com os critérios da ECC on Oral Problems Related to HIV Infection. A 
análise dos dados foi realizada mediante a aplicação de tabulações cruzadas, 
teste do Qui-quadrado e modelos de regressão logística.
RESULTADOS: Níveis de CD4+ < 350 células/mm³ (p < 0,001), consumo 
de álcool (p = 0,011) e sexo feminino (p = 0,031) foram predisponentes 
para candidíase bucal. A ocorrência de leucoplasia pilosa foi associada com 
contagens de CD4+ < 500 células/mm³ (p = 0,029), cargas virais > 5.000 
cópias/mm³ (p = 0,003) e tabagismo (p = 0,005).
CONCLUSÕES: Graus de imunodefi ciência moderados e severos e cargas virais 
detectáveis foram fatores de risco para o desenvolvimento de lesões bucais. 
O consumo de tabaco e álcool aumentou a suscetibilidade de desenvolver 
infecções oportunistas em adultos HIV positivos, independentemente do uso 
de terapia antirretroviral.
DESCRITORES: Infecções Oportunistas Relacionadas com a AIDS, 
epidemiologia. Manifestações Bucais. Fatores de Risco. Infecções por 
HIV. Síndrome de Imunodefi ciência Adquirida. Estudos Transversais.
INTRODUCTION
a Ministério da Saúde. Programa Nacional de Doenças Sexualmente Transmissíveis/AIDS. Bol Epidemiol DST/AIDS. 2011;8(1):3-21.
b Secretaria Municipal de Saúde de Porto Alegre, Coordenadoria Geral de Vigilância em Saúde, Equipe de Vigilância de DST. AIDS em Porto 
Alegre. Bol Epidemiol. 2011;13(45):2-3.
in the diagnosis and prognosis of HIV infection as well 
as in predicting therapy failure.11,14 An increased risk 
of developing HIV-associated oral manifestations in 
Brazilian samples has been associated with low CD4 
counts, high viral load (VL) levels, low income and 
schooling and addiction to tobacco and alcohol.6,15 
However, variations may be expected due to the hetero-
geneity of studied populations and the dynamic spread 
of HIV infection.
It is pertinent to determine the risk factors that lead to 
the onset of oral pathologies. This knowledge will allow 
a better understanding of the course of HIV infection 
and consequently, allow identifi cation of subjects that 
are at risk of developing oral affections and contributing 
to prevention and patient management.
Despite the elevated incidence of AIDS in adults 
from Porto Alegre, there are few studies available that 
evaluate risk factors for oral affections in HIV-positive 
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adults, especially with regard to VL.21 This study aimed 
to assess the risk factors for the occurrence of oral 
lesions in HIV-positive adults.
METHODS
The survey methodology was based on guidelines for 
the epidemiological study of oral lesions associated 
with HIV infection provided by the World Health 
Organization (WHO).9 We retrospectively reviewed 
the records of 534 HIV-positive adults who received 
medical or dental treatment at fi ve referral health centers 
in Porto Alegre city, Southern Brazil, between 1996 and 
2011. Only the records of subjects that matched prede-
termined inclusion criteria were sampled: aged 15 or 
over, an HIV-positive exam independently confi rmed 
by two enzyme-linked immunosorbent assay or western 
blot tests and the occurrence of any oral lesions at the 
time of the HIV diagnosis or during the course of the 
disease progression. The obtainability of sociode-
mographical, laboratory and clinical data were also 
considered for inclusion.
The included patients had been previously examined 
as a part of their routine medical management of 
HIV or other related illnesses. The oral evaluation of 
these patients was performed under non standardized 
physical assets by a non-calibrated infectologists 
or dentist specialized in oral medicine. The profes-
sionals were experienced in the management of HIV 
seropositive patients and in diagnosing related comor-
bidities, including oral manifestations of HIV/AIDS. 
Only the affections that were defi nitively diagnosed 
by their clinical features alone or those which were 
absolutely diagnosed through the completion of addi-
tional clinical and laboratory tests, according to the 
parameters of the WHO9 were included in the current 
survey. The data collection was classifi ed according 
to the criteria of EC-Clearinghouse on Oral Problems 
Related to HIV Infection.5
Sociodemographic (age, gender, race, marital status, 
occupation and tobacco, alcohol and illegal drug 
consumption), clinical (HIV-related oral lesions, anti-
retroviral therapy use) and laboratory (quantitative 
CD4+ cell count and VL) data were recorded using a 
standardized form. The considered information was 
that which was determined closest to the date of the 
oral lesion appearance with a maximum range of six 
months before and after.3,16
With regard to the risk factors related to an unhealthy 
lifestyle (use of tobacco, alcohol and illicit drugs), the 
subjects were classifi ed as users (who reported using 
legal or illegal substances in a period within six months 
before the onset of these affections) or non-users (who 
stopped the consumption of the noxious substances six 
months before the occurrence of oral lesions), according 
to data available on medical records.16
Categorical variables were described by counts and 
percentages with a 95% confi dence interval (95%CI) 
and binomial distribution. Quantitative variables 
with symmetrical distribution were described using 
mean and standard deviation (sd), and the variables 
with asymmetrical distributions were described using 
median and percentiles. Comparisons were analyzed 
using cross-tabulation, the Chi-square test and a multi-
variate logistic regression model that was adjusted for 
confounding factors. P ≤ 0.05 was determined to be 
statistically signifi cant.
Subject age was treated as a quantitative continuous 
variable and non-parametrically included in the logistic 
regression models. The sociodemographic character-
istics: gender (reference: masculine), race (reference: 
Caucasian), alcohol, tobacco and illicit drugs use (refer-
ence: non user) were equally considered as nominal and 
dichotomous. The categorical variables: CD4+ count (≥ 
500 cells/mm³, 350 to 500 cells/mm³, < 350 cells/mm³), 
VL level (> 20,000 copies/mm³, 5,001 to 20,000 copies/
mm³, 51 to 5,000 copies/mm³, ≤ 50 copies/mm³) and 
HAART use (compliant, noncompliant, not prescribed) 
were parametrically included in the regression models.
The data analyses were performed using the Statistical 
Package for the Social Sciences (SPSS®, Chicago, IL, 
USA) version 18.0 software program for Windows.
The study was conducted in compliance with the princi-
ples of the Helsinski Declaration and in agreement with 
the Brazilian-specifi c normative for research involving 
human subjects nº 196/96. It was also approved by 
the institutional review board of each participating 
institution Serviço de Estomatologia e Prevenção do 
Câncer Bucomaxilofacial e Serviço de Infectologia do 
Hospital São Lucas, Process nº 0092/2010, approved 
on November 17th, 2010; Centro de Especialidades 
Odontológicas do Hopital Nossa Senhora da 
Conceição, Process nº 11/011, approved on March 
16th, 2011, Centro de Saúde Vila dos Comerciários, 
Process nº 0010003281116, approved on February 8th, 
2011 and Centro de Testagem e Aconselhamento do 
Hospital Sanatório Partenon, approved on April 8th, 
2011; CAAE- 0392.0.002.164-11).
RESULTS
Of the 534 medical records, 51.7% of the patients were 
male, which resulted in a 1.1:1 male-to-female ratio. 
The mean age was 42.9 (sd = 11) years old, 68% of the 
subjects were Caucasian, 61.5% were single and 35.0% 
did not have any job connections. The demographic 
characteristics of the evaluated subjects were not statis-
tically different in gender (p = 0.328), age (p = 0.069), 
race (p = 0.295), marital status (p = 0.099) or occupa-
tion (p = 0.182), although they came from fi ve different 
health centers.
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Most of the oral lesions were diagnosed at a routine 
consultation, while 31.5% were observed during hospi-
talization. The median of CD4+ counts and VL of the 
patients sample was 242 cells/mm³ and 4,191 copies/
mm³, respectively (Table 1).
The use of HAART was mentioned in the medical 
records of 61.0% of patients; of those, 69.3% were 
in compliance with the treatment at the time of oral 
lesion occurrence. Poor adherence to the HAART was 
described in 30.7% of the patients’ records. However, 
38.6% had not previously used antiretroviral drugs. A 
combination of two nucleoside reverse transcriptase 
inhibitor plus a non-nucleoside reverse transcrip-
tase inhibitor (NNRTI) (Lamivudine/Zidovudine 
plus Efavirenz) were used for 50.0% of the treated 
individuals. Women were more susceptible to OC 
than men (OR 0.66, 95%CI 0.45;0.96, p = 0.031), 
and OC was also associated with chronic alcohol 
consumption (OR 2.38, 95%CI 1.22;4.67, p = 0.011). 
HL (OR 2.85, 95%CI 1.38;5.88, p = 0.005) was strongly 
associated with tobacco use. No correlations were 
observed between the different oral lesions and the 
proposed risk factors in the logistic regression analysis 
(Tables 2 and 3).
DISCUSSION
Moderate and severe degrees of immunodefi ciency and 
detectable viral loads were risk factors for the onset 
of oral lesions, irrespective of the use of HAART in 
Southern Brazil. Smoking and alcohol consumption 
contributed to a high susceptibility to the development 
of these affections in the evaluated subjects.
Table 1. The most prevalent oral lesions with respect to CD4+ and VL ranges. Porto Alegre, Southern Brazil, 2012.
Lesion
CD4+ (cells/mm³) (n = 534) Viral load (copies/mm³) (n = 534)
< 350
(n = 351)
350-500
(n = 82)
> 500
(n = 101)
 50
(n = 158)
51-5,000
(n = 118)
5,001-20,000
(n = 92)
> 20,000
(n = 166)
f % f % f % f % f % f % f %
OC 207 59.0 37 45.1 23 22.8 48 30.4 62 52.5 57 62.0 100 60.2
HL 42 12.0 10 12.2 1 1.0 5 3.2 8 6.8 22 23.9 18 10.8
KS 10 2.8 2 2.4 0 0.0 3 1.9 2 1.7 1 1.1 6 3.6
HSI 24 6.8 3 3.7 18 17.8 15 9.5 12 10.2 6 6.5 12 7.2
AOU 21 6.0 9 11.0 7 6.9 13 8.2 10 8.5 6 6.5 8 4.8
MP 10 2.8 4 4.9 12 11.9 14 8.9 7 5.9 2 2.2 3 1.8
LYM 45 12.8 14 17.1 9 8.9 22 13.9 12 10.2 10 10.9 24 14.5
OC: oral candidiasis (all types); HL: hairy leukoplakia; KS: Kaposi's sarcoma; HSI: herpes simplex infection; AOU: atypical 
oral ulceration; MP: melanocytic pigmentation; LYM: lymphadenitis
Table 2. Logistic regression models for oral candidiasis. Porto Alegre, Southern Brazil, 2012.
Variable
Univariate analysis Multivariate analysis
n OR 95%CI p OR 95%CI p
CD4+ (cells/mm3)
> 500 (reference) 23 1 1
350 to 500 37 2.79 1.47;5.27 0.002 2.47 1.26;4.84 0.009
< 350 207 4.88 2.92;8.13 < 0.001 3.82 2.16;6.77 < 0.001
VL (copies/mm³)
 50 (reference) 48 1 1
51-5,000 62 2.54 1.55;4.16 < 0.001 1.63 0.88;3.03 0.124
5,001-20,000 57 3.73 2.17;6.41 < 0.001 1.99 0.90;4.37 0.089
> 20,000 100 3.47 2.19;5.50 < 0.001 1.53 0.70;3.36 0.290
HAART
Compliant (reference) 66 1 1
Noncompliant 120 3.11 1.91;5.07 < 0.001 1.74 0.86;3.50 0.124
Not prescribed 81 2.70 1.83;3.99 < 0.001 1.70 0.90;3.20 0.103
OR: odds ratio obtained in a logistic regression model including the following terms: age, gender (male), race (Caucasian), 
smoking habit, alcohol consumption, illegaldrug use. Confi dence interval; p  0.05: statistical signifi cance
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No previous studies which evaluated a sample with 
similar characteristics or with the same scope had been 
conducted previously in this city, which has the greatest 
incidence of AIDS in Brazil.a One report evaluated the 
associations among HIV-associated oral lesions and 
CD4+ counts in 42 adults, inpatients, carriers of HIV 
and tuberculosis from Porto Alegre.21 The literature on 
this subject is scarce in the state.6,10
OC and HL have been associated with HIV since the 
beginning of the epidemic, but their prevalence has 
decreased after HAART began to be used. This fact 
is attributed to immune reconstitution accomplish-
ment after viral replication cessation due to the use of 
HAART.14 Our data indicate that OC and HL were the 
most common opportunistic infections, even among 
treated patients. These results confi rm previous esti-
mates obtained in surveys from Porto Alegre21 and other 
Brazilian reports.14,15
The univariate analyses showed that the subjects with 
moderate (OR 2.79, 95%CI 1.47;5.27, p = 0.002) and 
severe (OR 4.88, 95%CI 2.92;8.13, p < 0.001) degrees 
of immunosuppression were more susceptible to devel-
oping OC than those with mild or no immunologic 
impairment. These associations were also found in the 
multivariate analyses adjusted for several confounding 
factors, which demonstrated that patients with CD4+ 
counts between 350 and 500 cells/mm³ (OR 2.47, 
95%CI 1.26;4.84, p = 0.009) and under 350 cells/mm³ 
(OR 3.83, 95%CI 2.16;6.77, p < 0.001) had a statisti-
cally signifi cantly increased risk of developing OC than 
those with CD4+ counts higher than 500 cells/mm³.
Our data did not support the results of Volkweis et al in 
relation to the association between OC occurrence and 
immunosuppression.21 Similar fi ndings were reported 
by Aleixo et al2 and Lourenço & Figueiredo.8
A mild immunologic impairment (CD4+ 350 to 500 
cells/mm³) was suffi cient to increase the risk of devel-
oping HL nearly 11-fold (OR 10.57, 95%CI 1.27;87.92, 
p = 0.029). The multivariate logistic regression model 
showed that immunologic defi ciency could be consid-
ered to be an independently associated risk factor for 
the onset of these lesions, and similar statistics from 
Brazil confi rm this hypothesis.11,18 Moura et al12 which 
assessed the risk factors for HL in HIV-positive adults 
from Brazil, did not fi nd a relationship between CD4+ 
counts and this opportunistic infection. Among the 53 
carriers of HL observed, one presented CD4+ counts 
above 500 cells/mm³. The heterogeneous distribution 
of the sample may be responsible for the high OR 
values (Table 3).
The univariate model (Table 2) suggested that detect-
able VL (> 50 copies/mm³) was a risk factor for OC 
compared with undetectable circulating HIV-RNA. 
When this association is investigated together with 
CD4+ counts and use of HAART in a multivariate 
analysis, detectable VL did not augment the suscep-
tibility of developing this fungal infection. Of the 
267 patients who developed OC, 100 presented circu-
lating HIV-RNA levels that were higher than 20,000 
copies/mm.³ Despite the absence of signifi cance, the 
VL range of 5,001 to 20,000 copies/mm³ increased 
the risk of developing OC nearly 2-fold. Yielded the 
p (p = 0.089) and the extensive confi dence interval 
(0.90;4.37), the correlation between elevated VL and 
OC could not be conclusively excluded, despite the 
sample size and elevated number of adjustment factors.
Table 3. Logistic regression models for hairy leukoplakia. Porto Alegre, Southern Brazil, 2012.
Variable
Univariate analysis Multivariate analysis
n OR 95%CI p OR 95%CI p
CD4+ (cells/mm³)
> 500 (reference) 1 1 1
350 to 500 10 13.89 1.73;110.9 0.013 10.57 1.27;87.92 0.029
< 350 42 13.59 1.84;100.0 0.010 8.48 1.10;65.54 0.040
VL (copies/mm³)
 50 (reference) 5 1 1
51-5,000 8 2.22 0.71;6.99 0.170 1.97 0.56;6.99 0.293
5,001-20,000 22 9.62 3.50;26.44 <0.001 8.02 2.04;31.52 0.003
> 20,000 18 3.72 1.35;10.28 0.011 3.29 0.78;13.93 0.105
HAART
Compliant (reference) 13 1 1
Noncompliant 10 1.82 0.77;4.30 0.172 0.58 0.19;1.83 0.353
Not prescribed 30 2.79 1.41;5.52 0.003 1.05 0.38;2.87 0.928
OR: odds ratio obtained in a logistic regression model including the following terms: age, gender (male), race (Caucasian), 
smoking habit, alcohol consumption, illegaldrug use. Confi dence interval; p ≤ 0.05: statistical signifi cance
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HL was directly infl uenced by the progression of the 
infection. A VL level between 5,001 to 20,000 copies/
mm³ was independently associated with an augmented 
risk of developing HL (OR 8.02, 95%CI 2.04;31.52, 
p = 0.003) in the multivariate analysis. A longitudinal 
prospective study from Mexico, which provided the 
fi rst follow-up evaluation of the association of OC 
and HL with CD4+ counts and VL levels, showed 
that the occurrence of these pathologies is preceded 
by a sustained reduction of lymphocyte counts and an 
abrupt viral burden.16
Individuals with high VL levels may present a complete 
depletion of mucosal Langerhans cells, and this 
localized cytopathic effect causes the impairment of 
mucosal immunologic protection. This cellular event 
is associated with fungal and viral colonisation events 
(especially Epstein-Barr) in HIV-positive patients.5 The 
salivary levels of HIV-RNA may be higher than the 
plasma levels if they are enhanced by local infl amma-
tory conditions, which leads to the increased prevalence 
of oral manifestations.17
We acquired data from medical charts and the labora-
tory index considered included six-month intervals 
before and after the appearance of oral lesions. It is 
possible that elevations in VL levels and decreases 
in CD4+ cell count were not temporally coincident.3
The present study did not fi nd that OC and HL were 
inversely and signifi cantly associated with HAART 
use. This result is in contrast with other studies, which 
effectively considered these therapeutic agents as 
protection factors against oral lesions.14,16 Most patients 
who received HAART were treated with a drug combi-
nation that contained an NNRTI (Efavirenz). Ortega 
et al14 and da Silva et al18 observed a lower prevalence 
of oral lesions in patients undergoing HAART with 
NNRTI than patients who were treated with protease 
inhibitors. Therapy failure due to ineffectiveness or 
inadequate compliance, which was elevated among the 
observed patients, may explain our results.
The chronic consumption of alcoholic drinks was 
considered to be a risk factor for OC occurrence 
(OR = 2.38; CI = 1.22 to 4.67; p = 0.011), and the 
patients who smoked had the highest risk of developing 
HL (OR = 2.85; CI = 1.38 to 5.88; p = 0.005), which 
was independent of their CD4+ counts and VL levels.
Candida albicans oxidizes salivary ethanol, which 
leads to a high level of acetaldehyde production. This 
product affects the oral mucosa by augmenting its 
permeability, causing atrophic areas on the surface of 
the epithelia that became poor in extracellular lipids due 
to alcohol use. Glucose concentrations of 18 g/dL easily 
obtained from drinks increase biofi lm formation and 
C.albicans adhesion, which facilitates OC occurrence.20
The components of cigarette smoke may induce chronic 
infl ammation on the oral mucosae, cause damage to the 
innate immunity mechanisms against pathogens and 
inhibit cell growth by apoptosis mechanisms. These 
effects of smoking reduce the production of salivary 
enzymes and immunoglobulins and affect the production 
of lymphocytes, resulting in an imbalance of the oral 
microfl ora. These modifi cations probably encourage 
EBV infectivity, promoting the occurrence of HL.7
Female gender was associated with OC occurrence. 
Lourenço & Figueiredo8 described the same fi nding in 
Brazilian patients. The relationship between feminine 
sexual hormones and oral fl ora remains unclear. Down-
regulated levels of oestrogen would predispose the oral 
mucosae to C.albicans colonization. This hormone acted 
as a protection factor for vaginal candidiasis,13 possibly 
in lower levels of oestrogen both tissues, oral and vaginal 
remain more susceptible to fungal infections.
A wide spectrum of oral diseases have been associated 
with HIV/AIDS since the beginning of the epidemic.5 
The onset of certain affections can provide valuable 
clinical information on HIV progression.8 Several 
of these manifestations can be accurately diagnosed 
based exclusively on their clinical features.5,9 Oral 
examination is an inexpensive and simple procedure 
and should be mandatory for HIV carriers, especially 
in low-income settings.19
The limitations of our study are inherent to data collec-
tion from medical records not explicitly designed 
to explore HIV-associated oral lesions. Oral lesions 
may be under-reported, leading to a sub-estimation 
of prevalence. Both HIV carriers and AIDS patients 
were included. This fact would have also infl uenced 
the prevalence of some oral affections. Some condi-
tions have a stronger association with HIV-infection 
and a few are defi nitively AIDS defi ning, possibly 
due to local and systemic immune variations.4,17 
Symptomatic individuals are most at risk of being 
affected by other systemic opportunistic diseases, 
which possibly enhanced the risk of developing certain 
oral affections.18 Furthermore, we reported data from 
a single evaluation.
The retrospective analyses made comparison of our 
results with those presented in prospective surveys diffi -
cult. Although the accessible data carefully collected may 
refl ect reliable and relevant information on risk factors 
for oral lesion development in the observed HIV-carriers, 
they cannot be inferred for the whole population.
Longitudinal studies are needed to explore the dynamics 
of the relationship between the VL levels and CD4+ 
counts preceding the onset of HIV-related oral lesions, 
especially OC and HL, such as the ability of these 
pathologies to predict changes in these laboratory 
indices. These results will emphasize the potential 
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use of oral opportunistic infections as early clinical 
markers of disease progression and HAART failure. 
This validation is of great importance in countries with 
limited resources, and there are limited data available 
from the developing world.
The results suggest that elevated VL levels and low 
CD4+ counts are risk factors for HL. Moderate to 
severe degrees of immunologic impairment increased 
the susceptibility of developing OC and HL in adult 
carriers of HIV. It is necessary to improve prevention, 
early diagnosis and the management of these patholo-
gies in symptomatic patients, who are more susceptible 
to opportunistic diseases. Alcohol and tobacco are 
modifi able habits that should be discontinued since 
they have been shown to be predisposing factors for 
OC and HL. We did not obtain suffi cient information 
on substance abuse to make this a reliable independent 
variable in evaluating its effects on oral health. More 
studies are necessary in this fi eld, especially applying a 
more precise measurement of drug abuse. Case-control 
studies including HIV-positive subjects under HAART 
and healthy controls are required to clarify the true 
contribution of alcohol and tobacco to the onset of 
HIV-related oral lesions.
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